Thyroid dysfunction during treatment with atypical antipsychotics.
Greenspan
Andrew
A
Gharabawi
Georges
G
Kwentus
Joseph
J
D014150:Antipsychotic Agents / Q000009:adverse effects* / Q000627:therapeutic use*; D003987:Dibenzothiazepines / Q000009:adverse effects / Q000627:therapeutic use; D004311:Double-Blind Method; D006801:Humans; D006980:Hyperthyroidism / Q000097:blood / Q000139:chemically induced / Q000175:diagnosis; D007037:Hypothyroidism / Q000097:blood / Q000139:chemically induced / Q000175:diagnosis; D010919:Placebos; D000069348:Quetiapine Fumarate; D016032:Randomized Controlled Trials as Topic; D018967:Risperidone / Q000009:adverse effects / Q000627:therapeutic use; D012559:Schizophrenia / Q000097:blood / Q000188:drug therapy*; D013960:Thyroid Function Tests; D013963:Thyroid Hormones / Q000097:blood*
D014150:Antipsychotic Agents; D003987:Dibenzothiazepines; D010919:Placebos; D013963:Thyroid Hormones; D000069348:Quetiapine Fumarate; D018967:Risperidone